Spots Global Cancer Trial Database for locally advanced rectal adenocarcinoma
Every month we try and update this database with for locally advanced rectal adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer | NCT03300544 | Locally Advance... Metastatic Rect... Rectal Adenocar... Stage III Recta... Stage IIIA Rect... Stage IIIB Rect... Stage IIIC Rect... Stage IV Rectal... Stage IVA Recta... Stage IVB Recta... | Capecitabine Fluorouracil Leucovorin Oxaliplatin Radiation Thera... Talimogene Lahe... | 18 Years - | National Cancer Institute (NCI) | |
| XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma | NCT00557713 | Rectal Neoplasm... Locally Advance... | bevacizumab | 18 Years - | Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials | |
| XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma | NCT00557713 | Rectal Neoplasm... Locally Advance... | bevacizumab | 18 Years - | Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials | |
| INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer | NCT04130854 | Locally Advance... | APX005M, mFOLFO... mFOLFOX and Rad... | 18 Years - 99 Years | University of Texas Southwestern Medical Center | |
| Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer | NCT02874885 | Locally Advance... Metastatic Rect... Rectosigmoid Ad... Recurrent Recta... Recurrent Recto... Stage III Recta... Stage IIIA Rect... Stage IIIB Rect... Stage IIIC Rect... Stage IV Rectal... Stage IVA Recta... Stage IVB Recta... Stage IVC Recta... | Biospecimen Col... | 18 Years - | M.D. Anderson Cancer Center | |
| Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer | NCT04751370 | Locally Advance... Stage II Rectal... Stage III Recta... | Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab Radiation Thera... Sigmoidoscopy Total Mesorecta... | 18 Years - | National Cancer Institute (NCI) | |
| Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer | NCT04751370 | Locally Advance... Stage II Rectal... Stage III Recta... | Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab Radiation Thera... Sigmoidoscopy Total Mesorecta... | 18 Years - | National Cancer Institute (NCI) | |
| Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer | NCT03300544 | Locally Advance... Metastatic Rect... Rectal Adenocar... Stage III Recta... Stage IIIA Rect... Stage IIIB Rect... Stage IIIC Rect... Stage IV Rectal... Stage IVA Recta... Stage IVB Recta... | Capecitabine Fluorouracil Leucovorin Oxaliplatin Radiation Thera... Talimogene Lahe... | 18 Years - | National Cancer Institute (NCI) | |
| INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer | NCT04130854 | Locally Advance... | APX005M, mFOLFO... mFOLFOX and Rad... | 18 Years - 99 Years | University of Texas Southwestern Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
